HSBC 2002 Annual Report Download - page 310

HSBC HOLDINGS PLC
Notes on the Financial Statements (continued)
308
beginning after 15 December 1994. SFAS 114 addresses accounting by creditors for impairment of a loan by
specifying how allowances for credit losses for certain loans should be determined. A loan is impaired when it is
probable that the creditor will be unable to collect all amounts in accordance with the contractual terms of the
loan agreement. Impairment is measured based on the present value of expected future cash flows discounted at
the loan’ s effective rate or, as an expedient, at the fair value of the loan’ s collateral. Leases, smaller-balance
homogeneous loans and debt securities are excluded from the scope of SFAS 114.
At 31 December 2002, HSBC estimated that the difference between the carrying value of its loan portfolio on
the basis of SFAS 114 and its value in HSBC’ s UK GAAP financial statements was such that no adjustment to
net income or shareholders’ equity was required.
Impaired loans are those reported by HSBC as non-performing; the value of such loans at 31 December 2002
amounted to US$10,520 million (2001: US$9,658 million). Of this total, loans which were included within the
scope of SFAS 114 and for which a provision has been established amounted to US$8,294 million (2001:
US$8,085 million). The impairment reserve in respect of these loans estimated in accordance with the
provisions of SFAS 114 was US$4,868 million (2001: US$4,441 million). During the year ended 31 December
2002, impaired loans, including those excluded from SFAS 114, averaged US$9,153 million (2001: US$9,617
million) and interest income recognised on these loans was US$258 million (2001: US$261 million; 2000:
US$324 million).
(n) Fair value of financial instruments
SFAS 107 ‘Disclosures about Fair Value of Financial Instruments’ requires disclosure of the estimated fair
values of certain financial instruments, both on-balance-sheet and off-balance-sheet, where it is practicable to do
so.
Where possible, fair values have been estimated using market prices for the financial instruments. Where market
prices are not available, fair values have been estimated using quoted prices for financial instruments with
similar characteristics, or otherwise using a suitable valuation technique where practicable to do so. The fair
value information presented represents HSBC’ s best estimate of those values and may be subject to certain
assumptions and limitations.
The fair values presented in the table on page 310 are at a specific date and may be significantly different from
the amounts which will actually be paid or received on the maturity or settlement date. In many cases, the
estimated fair values could not be realised immediately and accordingly do not represent the value of these
financial instruments to HSBC as a going concern.
HSBC has excluded the fair value of intangible assets, such as values placed on its portfolio of core deposits,
credit card relationships and customer goodwill, as these are not considered to constitute financial instruments
for the purposes of SFAS 107. HSBC believes such items to be significant and essential to the overall evaluation
of HSBC’ s worth.
In view of the above, comparisons of fair values between financial institutions may not be meaningful and users
are advised to exercise caution when using this data.
Financial instruments for which fair value is equal to carrying value
The following table lists those financial instruments, within the scope of SFAS 107, where carrying value is an
approximation of fair value because they are either (i) carried at market value or (ii) short term in nature or
reprice frequently. By definition, the fair value of trading account assets and liabilities, including derivative
instruments, equals carrying value. Carrying values of these instruments are presented on the balance sheets and
related notes on pages 191 to 313.